List of insiders holdings for GENEREX BIOTECHNOLOGY CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Von Hofe Eric President of Subsidiary | 2016-02-12 16:11:45 | 7,610,911 0 | 7,610,911 | Form 4 |
| BARRATT JOHN P Director | 2015-04-27 16:00:40 | 5,874,162 0 | 5,874,162 | Form 4 |
| Brusegard David Chief Operating Officer | 2016-02-16 17:03:52 | 5,615,070 0 | 5,615,070 | Form 4 |
| PERRI ROSE C Director | 2011-05-11 10:35:57 | 975,478 3,700,076 | 4,675,554 | Form 4 |
| GLUSKIN ANNA E CEO & President | 2010-03-10 16:12:38 | 1,870,704 0 | 1,870,704 | Form 4 |
| FELLOWS STEPHEN Chief Financial Officer | 2016-02-12 16:13:06 | 1,667,671 0 | 1,667,671 | Form 4 |
| Masterson Nola E Director | 2012-07-05 16:34:37 | 508,197 0 | 508,197 | Form 4 |
| Salvo Lawrence Anthony Sr Director | 2019-05-14 14:05:23 | 320,345 0 | 320,345 | Form 3 |
| Wires David E Director | 2006-06-01 14:11:27 | 164,300 7539 | 171,839 | Form 3 |
| ALLPORT SETTLE MINDY J Director | 2006-06-01 13:33:31 | 153,100 0 | 153,100 | Form 4 |
| Amanatides Peter Director | 2006-06-01 13:31:20 | 151,000 0 | 151,000 | Form 4 |
| LEVITCH PETER Director | 2003-11-18 16:58:30 | 140,000 0 | 140,000 | Form 4 |
| ROSEN J MICHAEL Director | 2003-11-18 16:35:53 | 120,000 0 | 120,000 | Form 4 |
| BERNSTEIN GERALD VP, Medical Affairs | 2010-03-10 16:10:03 | 100,000 0 | 100,000 | Form 4 |
| FLETCHER MARK EVP General Counsel &Secretary | 2018-10-15 16:16:14 | 20,125 0 | 20,125 | Form 4 |
| Corrao Mark CFO & Treasurer | 2018-10-15 16:15:51 | 4500 0 | 4500 | Form 4 |
| Purcell Richard David Jr. SVP of Research & Drug Develop | 2018-10-15 16:17:20 | 4500 0 | 4500 | Form 4 |
| Ro Andrew SVP & Chief Investment Officer | 2018-10-15 16:18:17 | 4500 0 | 4500 | Form 4 |
| Prioletti Mark Joseph SE Director | 2019-09-11 15:45:59 | 3568 0 | 3568 | Form 3 |
| MCGEE BRIAN Director | 2018-10-15 16:17:00 | 1070 0 | 1070 | Form 4 |
| Anderson James H Jr. Director | 2018-10-15 16:14:49 | 1000 0 | 1000 | Form 4 |
| Centofanti Kevin Director | 2018-10-15 16:15:29 | 1000 0 | 1000 | Form 4 |
| Lyman Gary Herbert Director | 2018-10-15 16:16:40 | 1000 0 | 1000 | Form 4 |
| Haines Harold Gray Consultant | 2018-12-14 14:31:30 | 945 0 | 945 | Form 4 |